Wilma Erhardt is currently the Group Director of Health Economics and Payer Evidence for Respiratory & Immunology at AstraZeneca, where they lead a team of experts in health economics and payer evidence. From 2009 to 2011, Wilma served as an Outcomes Research Manager at Bristol-Myers Squibb, focusing on health economics in oncology and virology. They also held positions at Janssen Pharmaceutical Companies from 2011 to 2018, where they founded and led a team in health economics and outcomes research, alongside roles in market access and pricing. Wilma began their career with internships at Roche Pharmaceuticals between 2002 and 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices